binx health Announces Publication of Pivotal Study in JAMA Network Open

Study signals “real paradigm shift” in care resulting from the world’s first FDA-cleared, 30-minute, molecular point-of-care platform for the detection of chlamydia and gonorrhea


binx health Announces Second FDA 510(k) Clearance of its Molecular Point-of-Care Infectious Disease Platform

Latest FDA clearance establishes binx as the fastest dual-gender rapid test-and-treat platform for chlamydia and gonorrhea

COVID-19 pandemic has created growing backlog of millions in need of routine STI testing


Fortune Magazine featured binx health’s io as a healthcare “breakthrough,” as it expands access to high quality chlamydia and gonorrhea testing at point of care sites across the US

binx health was featured in Fortune Magazine highlighting the io platform as not only the first and fastest FDA-cleared molecular point-of-care diagnostic for the detection of chlamydia and gonorrhea, but…

binx blog

Revolutionizing STI Diagnostics

Sexually transmitted infections (STIs/STDs) are the most commonly reported infectious conditions in the U.S. The majority of these infections are easy to detect and treat but their rates continue to…

Woman with curly hair hugging man with glasses from behind.
binx blog

Rising STD Rates Reported for the 5th Year

What is the state of Sexually Transmitted Diseases (STDs) today? Last fall, the Centers for Disease Control and Prevention (CDC) reported the highest ever STD rates in the U.S. The…

binx blog

How can you get an STI?

It’s reasonable to assume that all sexually transmitted infections (STIs) – a.k.a. sexually transmitted diseases (STDs) – are transmitted through sexual contact. While that may be true, it’s only part…

binx blog

5 Steps Towards Sexual Health

To celebrate World Sexual Health Month 2019 we’re bringing you a 5-step guide to improving your sexual health. With the start of fall and the new school year in full…

Placing STI cartridge into POC Desktop Instrument

binx health Announces First Patients Benefiting from Single-Visit Test and Treatment for Chlamydia and Gonorrhea

binx FDA-cleared platform already impacting human health—poised to transform care for millions

binx health announces second FDA 510(K) clearance of its molecular point-of-care infectious disease platform.